检索结果-南通市图书馆

上海造船 2011年第1期 72-79页

作者： takehiro inoue Yoshiya Yamaguchi Hiroshi Yajima ShujiAihara Hitoshi Yoshinari Kazuhiro Hirota Masanobu Toyoda Takaaki Kiyosue Tsunehisa Handa Tomoya Kawabata Tokutaka Tani 许立人日本钢铁公司日本海事协会长崎应用科学研究所东京大学国家海事研究所三菱重工有限公司 IHI船舶联合公司川崎造船公司 JFE钢铁公司住友金属工业有限公司神户制钢有限公司

对船用钢进行长裂纹止裂特性研究表明:它们的脆性裂纹止裂能力不够。TMCP钢有足够的脆性裂纹止裂能力。对船用钢进行了两种实尺(actual-scale)模型试验,明确了脆性裂纹扩展的条件。根据试验结果提出了止裂韧度值Kca,已经归纳在"脆性裂... 详细信息

对船用钢进行长裂纹止裂特性研究表明:它们的脆性裂纹止裂能力不够。TMCP钢有足够的脆性裂纹止裂能力。对船用钢进行了两种实尺(actual-scale)模型试验,明确了脆性裂纹扩展的条件。根据试验结果提出了止裂韧度值Kca,已经归纳在"脆性裂纹止裂设计指导性文件"中。

关键词：脆性裂纹长裂纹止裂试验止裂韧度

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

引用

World Journal of Gastroenterology 2008年第47期14卷 7225-7230页

作者： Takayuki Kogure Yoshiyuki Ueno Koji Fukushima Futoshi Nagasaki Yasuteru Kondo Jun inoue Yasunori Matsuda Eiji Kakazu Takeshi Yamamoto Hiroyoshi Onodera Yutaka Miyazaki Hiromasa Okamoto takehiro Akahane Tomoo Kobayashi Yutaka Mano Takao Iwasaki Motoyasu Ishii Tooru Shimosegawa Division of Gastroenterology Tohoku University HospitalSendai 980-8574Japan Department of Gastroenterology Tohoku Rosai HospitalSendai 980-8574Japan Department of Gastroenterology Miyagi Cancer CenterNatori 981-1293Japan Department of Internal Medicine Tohoku Kosai HospitalSendai 980-0803Japan Department of Internal Medicine Shirakawa Kosei General HospitalShirakawa 961-0005Japan Department of Gastroenterology Ishinomaki Municipal HospitalIshinomaki 986-0835Japan Department of Gastroenterology Osaki Citizen HospitalFurukawa 989-6183Japan Department of Gastroenterology Sendai Medical CenterSendai 983-8520Japan Department of Internal Medicine Miyagi Social Insurance HospitalSendai 981-1103Japan

AIM:To evaluate the efficacy of pegylated interferon α-2b(peg-IFNα-2b) plus ribavirin(RBV) therapy in Japanese patients with chronic hepatitis C(CHC) genotype Ib and a high viral ***:One hundred and twenty CHC patients(58.3% male) who received peg-IFNα-2b plus RBV therapy for 48 wk were *** virological response(SVR) and clinical parameters were ***:One hundred(83.3%) of 120 patients completed 48 wk of treatment.53 patients(44.3%) achieved *** virological response(EVR) and end of treatment response(ETR) rates were 50% and 73.3%,*** clinical parameters(SVR vs non-SVR) associated with SVR,ALT(108.4 IU/L vs 74.5 IU/L,P = 0.063),EVR(76.4% vs 16.4%,P 56 years),SVR in females was significantly lower than that in males(17% vs 50%,P = 0.0262).EVR and adherence to Peg-IFN were demonstrated to be the main factors associated with ***:Peg-IFNα-2b plus RBV combination therapy demonstrated good tolerability in Japanese patients with CHC and resulted in a SVR rate of 44.3%.Treatment of elderly female patients is still challenging and maintenance of adherence to peg-IFNα-2b is important in improving the SVR rate.

关键词： Chronic hepatitis C Pegylated interferon Ribavirin

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

An experience of hyperbaric oxygen and transurethral coagulation combination therapy for abnormal vessels and intractable macrohematuria due to pelvic arteriovenous malformations

引用

Case Reports in Clinical Medicine 2013年第7期2卷 399-401页

作者： Seiya inoue Masashi Honda Shinji Hirano Noriya Yamaguchi Bunya Kawamoto Tsounapi Panagiota Katsuya Hikita Kuniyasu Muraoka takehiro Sejima Chihiro Takahashi Atsushi Takenaka Department of Urology National Hospital Organization Yonago Medical Center Yonago Japan Department of Urology National Hospital Organization Yonago Medical Center Yonago Japan of Urology Tottori University School of Medicine Yonago Japan Department of Urology Tottori University School of Medicine Yonago Japan Department of Urology Tottori University School of Medicine Yonago Japan

A 78-year-old man was admitted to our hospital with a chief complaint of gross hematuria. The patient was diagnosed with pelvic arteriovenous malformations and repeated arterial embolization. A cystoscopy demonstrated that bladder trigone was covered by many clots. At the same time, bleeding mucosa at the right side of the bladder dome was confirmed. We administered hyperbaric oxygen therapy 7 days after admission. Macrohematuria recovered gradually and we then performed transurethral coagulation at the dome with failed mucosa 14 days after admission. Macrohematuria recovered completely and there was no recurrence during hospitalization. Thirty days after admission, we performed cystoscopy and found clear mucosa in the trigone. The patient was discharged 32 days after admission.

关键词： Hyperbaric Oxygen Therapy Macrohematuria Pelvic Arteriovenous Malformations Transurethral Coagulation

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：